✦ LIBER ✦

9157 Retrospective review of efficiency of erlotinib or pemetrexed or docetaxel compared to docetaxel as subsequent line therapy in advanced non-small cell lung cancer (NSCLC) following failure of platinum-based chemotherapy

✍ Scribed by Almodovar, M.T.; Luis, A.; Ferreira, M.P.; da Costa, J. Duro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brief report: Retrospective review of ef

✍ Ng, Raymond; Loreto, Michael; Lee, Roy; Leighl, Natasha B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

PD-068 An exploratory analysis of a phas

✍ Bunn, P.; Rosell, R.; Fossella, F.; Perry, M.; Stahel, R.; Barata, F.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

P-43 Randomised phase III trial of docet

✍ Booton, Richard; Campbell, Daniel; Ward, Tim; Ashcroft, L.; Power, Fiona; Taylor 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 348 KB

P-488 Phase II randomized trial of singl

✍ Gridelli, C.; Reck, M.; Gregorc, V.; Migliorino, M.; Muller, T.; Manegold, C.; F 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

9147 Bevacizumab and erlotinib as first-

✍ Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Preliminary results of a randomized stud

✍ Quoix, E; Lebeau, B; Jacoulet, P; Ducolonné, A; Moro, D; Milleron, B; Lemarié, E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB